HLA typing is commonly referred as Human Leukocyte Antigen which is used to check how closely tissue of donor matches with tissue of recipient before transplantation. HLA are proteins which inherited from the parents. HLA matching helps in development and growth of new healthy food cells and also eliminates risk of post-transplant complication.
Market Drivers
Rise in number of transplant procedures is the key driving factor which is expected to boost the global HLA typing for transplant market growth. Furthermore, continuous technological advancements in HLA typing will have the positive impact on market growth. Moreover, rise in public-private funding for target research activities will fuel the market growth. In addition to that, increase in geriatric population will fuel the market growth. Also, rise in number of older adults are becoming organ donors which expected to propel the market growth.
Market Restraints
However, high cost of molecular tests used for HLA typing procedures is the major restraining factor which is expected to hamper the global HLA typing for transplant market growth. Also, significant gap between the number of organ donors and organs required annually will affect the market growth.
Market Segmentation
Global HLA Typing for Transplant Market is segmented into type such as Molecular Assays, and Non-Molecular Assays, by application such as Diagnostic Applications, and Research Applications. Further, market is segmented into end user such as Hospitals & Transplant Centers, Commercial Service Providers, and Research Laboratories and Academic Institutes.
Also, Global HLA Typing for Transplant Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market Key Players
Various key players are discussed in this report such as THERMO FISHER SCIENTIFIC, F. HOFFMAN-LA ROCHE LIMITED, QIAGEN, IMMUCOR, ABBOTT LABORATORIES INC., CAREDX, INC., ILLUMINA, BIO-RAD LABORATORIES, ALPHA BIOTECH, LTD., and GENDX
Market Taxonomy
By Type
By Application
By End User
By Region
Key Questions Addressed by the Report
Global HLA Typing For Transplant Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global HLA Typing For Transplant Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global HLA Typing For Transplant Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global HLA Typing For Transplant Market Share Analysis, By Type
5.3 Global HLA Typing For Transplant Market Size and Forecast, By Type
5.3.1 Molecular Assays
5.3.2 Non-Molecular Assays
6 Global HLA Typing For Transplant Market , By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global HLA Typing For Transplant Market Share Analysis, By Application
6.3 Global HLA Typing For Transplant Market Size and Forecast, By Application
6.3.1 Diagnostic Application
6.3.2 Research Applications
7 Global HLA Typing For Transplant Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global HLA Typing For Transplant Market Share Analysis, By End User
7.3 Global HLA Typing For Transplant Market Size and Forecast, By End User
7.3. 1 Hospitals & Transplant Centres
7.3.2 Commercial Service Providers
7.3.3Research Laboratories & Academic Institutes
8Global HLA Typing For Transplant Market, By Region
8.1 Global HLA Typing For Transplant Market Share Analysis, By Region
8.2 Global HLA Typing For Transplant Market Share Analysis, By Region
8.3 Global HLA Typing For Transplant Market Size and Forecast, By Region
9 North America HLA Typing For Transplant Market Analysis and Forecast (2017 – 2030)
9.1 Introduction
9.2 North America HLA Typing For Transplant Market Share Analysis, By Type
9.3 North America HLA Typing For Transplant Market Size and Forecast, By Application
9.4 North America HLA Typing For Transplant Market Size and Forecast, By End User
9.5 North America HLA Typing For Transplant Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10Europe HLA Typing For Transplant Market Analysis and Forecast (2017 – 2030)
10.1 Introduction
10.2 Europe HLA Typing For Transplant Market Share Analysis, By Type
10.3 Europe HLA Typing For Transplant Market Size and Forecast, By Application
10.4 Europe HLA Typing For Transplant Market Size and Forecast, By End User
10.5 Europe HLA Typing For Transplant Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific HLA Typing For Transplant Market Analysis and Forecast (2017 – 2030)
11.1 Introduction
11.2 Asia Pacific HLA Typing For Transplant Market Share Analysis, By Type
11.3 Asia Pacific HLA Typing For Transplant Market Size and Forecast, By Application
11.4 Asia Pacific HLA Typing For Transplant Market Size and Forecast, By End User
11.5 Asia Pacific HLA Typing For Transplant Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America HLA Typing For Transplant Market Analysis and Forecast (2017 – 2030)
12.1 Introduction
12.2 Latin America HLA Typing For Transplant Market Share Analysis, By Type
12.3 Latin America HLA Typing For Transplant Market Size and Forecast, By Application
12.4 Latin America HLA Typing For Transplant Market Size and Forecast, By End User
12.5 Latin America HLA Typing For Transplant Market Size and Forecast, Country
13Middle East HLA Typing For Transplant Market Analysis and Forecast (2017 – 2030)
13.1 Introduction
13.2 Middle East HLA Typing For Transplant Market Share Analysis, By Type
13.3 Middle East HLA Typing For Transplant Market Size and Forecast, By Application
13.4 Middle East HLA Typing For Transplant Market Size and Forecast, By End User
13.5 Middle East HLA Typing For Transplant Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 THERMO FISHER SCIENTIFIC
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 F. HOFFMAN-LA ROCHE LIMITED
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 QIAGEN, IMMUCOR
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 ABBOTT LABORATORIES
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 CAREDX, INC
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 ILLUMINA
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 BIO-RAD LABORATORIES
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 ALPHA BIOTECH
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 GENDX
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
